Literature DB >> 22772856

Fever in sepsis.

F Schortgen1.   

Abstract

Fever is a common symptom of sepsis usually believed to predict better survival. Experimental data suggest that body temperature elevation may slow micro-organism growth and enhance host immune responses. In patients with sepsis, however, the high energy cost of fever may exacerbate the life-threatening situation. Fever control is widely used in the ICU, mainly in patients with infections. The efficacy of antipyretic drugs in lowering body temperature remains uncertain, however, and all antipyretics have well known adverse effects. Surface cooling methods are efficient but require sedation to avoid the harmful effects of shivering. A recent controlled trial in patients with septic shock suggests that external cooling for fever control may diminish vasopressor requirements and improve early survival. In this review, we examine the benefits and risks of fever and of controlled normothermia. The fever control modalities that provide the best risk/benefit ratio in sepsis are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772856

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  11 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

2.  Integrative genomics identifies 7p11.2 as a novel locus for fever and clinical stress response in humans.

Authors:  Jane F Ferguson; Nuala J Meyer; Liming Qu; Chenyi Xue; Yichuan Liu; Stephanie L DerOhannessian; Melanie Rushefski; Georgios K Paschos; Soonyew Tang; Eric E Schadt; Mingyao Li; Jason D Christie; Muredach P Reilly
Journal:  Hum Mol Genet       Date:  2014-11-20       Impact factor: 6.150

3.  Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.

Authors:  Frédérique Schortgen; Anaïs Charles-Nelson; Lila Bouadma; Geoffray Bizouard; Laurent Brochard; Sandrine Katsahian
Journal:  Intensive Care Med       Date:  2015-07-23       Impact factor: 17.440

4.  Mouse sepsis models: don't forget ambient temperature!

Authors:  Dario Lucas Helbing; Leonie Karoline Stabenow; Reinhard Bauer
Journal:  Intensive Care Med Exp       Date:  2022-07-01

5.  Assessing structural and functional response of murine vasculature to acute β-adrenergic stimulation in vivo during hypothermic and hyperthermic conditions.

Authors:  Anna C Crouch; Paige E Castle; Lauryn N FitzGerald; Ulrich M Scheven; Joan M Greve
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

6.  Predicting 30-day mortality in patients with sepsis: An exploratory analysis of process of care and patient characteristics.

Authors:  Miriam Sanderson; Marc Chikhani; Esme Blyth; Sally Wood; Iain K Moppett; Tricia McKeever; Mark Jr Simmonds
Journal:  J Intensive Care Soc       Date:  2018-02-19

7.  Outcome of severe infections in afebrile neutropenic cancer patients.

Authors:  Ksenija Strojnik; Ksenija Mahkovic-Hergouth; Barbara Jezersek Novakovic; Bostjan Seruga
Journal:  Radiol Oncol       Date:  2016-02-10       Impact factor: 2.991

Review 8.  Fever: Could A Cardinal Sign of COVID-19 Infection Reduce Mortality?

Authors:  Stephen A Hoption Cann
Journal:  Am J Med Sci       Date:  2021-01-09       Impact factor: 2.378

9.  Storage related haematological and biochemical changes in Plasmodium falciparum infected and sickle cell trait donor blood.

Authors:  Enoch Aninagyei; Emmanuel Tetteh Doku; Patrick Adu; Alexander Egyir-Yawson; Desmond Omane Acheampong
Journal:  BMC Hematol       Date:  2018-11-06

10.  Impact of ambient temperature on inflammation-induced encephalopathy in endotoxemic mice-role of phosphoinositide 3-kinase gamma.

Authors:  Guang-Ping Lang; Bernadin Ndongson-Dongmo; Trim Lajqi; Michael Brodhun; Yingying Han; Reinhard Wetzker; Martin G Frasch; Reinhard Bauer
Journal:  J Neuroinflammation       Date:  2020-10-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.